12-O-(2-Methylbutyroyl)phorbol-13-dodecanoate | 250268-59-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 12-O-(2-Methylbutyroyl)phorbol-13-dodecanoate
• 英文别名: [(1S,2S,6R,10S,11R,13S,14R,15R)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-(2-methylbutanoyloxy)-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] dodecanoate
• CAS: 250268-59-8
• 化学式: C₃₇H₅₈O₈
• 分子量: 630.8
• InChiKey: HNUDFMQYCDPTHE-QPUDZDCCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.9
• 重原子数：
  45
• 可旋转键数：
  17
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  130
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• Method of Producing Progenitor Cells from Differentiated Cells
  申请人：Bhasin Vishal

  公开号：US20120121546A1

  公开（公告）日：2012-05-17

  The present invention provides a method of producing progenitor cells, such as cells capable of being differentiated into a plurality of different cell types, from differentiated cells. Methods of using progenitor cells in differentiation and/or tissue or organ repair and/or regeneration and/or building are also provides. Methods of using progenitor cells in treatment and prophylaxis of conditions alleviated by administering stem cells or tissue or organ derived from stem cells to a subject or by grafting stem cells or tissue or organ derived from stem cells into a subject or by transplanting stem cells or tissue or organ derived from stem cells into a subject are also provided. Also included are progenitor cells and differentiated cells and/or tissues and/or organs derived therefrom, and kits comprising same.
• METHOD OF PRODUCING PROGENITOR CELLS FROM DIFFERENTIATED CELLS
  申请人：Regenertech PTY Limited

  公开号：US20180171290A1

  公开（公告）日：2018-06-21

  The present invention provides a method of producing progenitor cells, such as cells capable of being differentiated into a plurality of different cell types, from differentiated cells. Methods of using progenitor cells in differentiation and/or tissue or organ repair and/or regeneration and/or building are also provided. Methods of using progenitor cells in treatment and prophylaxis of conditions alleviated by administering stem cells or tissue or organ derived from stem cells to a subject or by grafting stem cells or tissue or organ derived from stem cells into a subject or by transplanting stem cells or tissue or organ derived from stem cells into a subject are also provided. Also included are progenitor cells and differentiated cells and/or tissues and/or organs derived therefrom, and kits comprising same.
• US6268395B1
  申请人：——

  公开号：US6268395B1

  公开（公告）日：2001-07-31